Literature DB >> 31376261

Animal models of Sjögren's syndrome: an update.

Fan Xiao1, Man Han2, Xiaohui Wang1, Xun Gong2, Enyu Huang1, Zhenhang Zhu3, Futao Zhao3, Yan Zhao4, Quan Jiang5, Liwei Lu6.   

Abstract

Sjögren's syndrome (SS) is a chronic autoimmune disease characterised by lymphocytic infiltration in exocrine glands with secretory dysfunction. Although both environmental triggers and genetic predisposition have been recognised as important factors in the initiation and development of SS, the pathogenesis of SS is complex and still largely unclear. Animal models have served as useful tools for studying SS pathogenesis with several advantages. A number of animal models recapitulating key characteristics of primary SS patients including secretory dysfunction, glandular inflammation and presence of autoantibodies were developed in the past years. The studies based on the animal models of SS have provided significant insight in SS pathogenesis and therapeutic intervention. This review summarises current animal models with primary SS-like symptoms including spontaneous models, genetically modified models, induced models and humanised models, and discusses their contribution to the understanding of SS aetiology and therapies.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31376261

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  6 in total

Review 1.  The NZB/W F1 mouse model for Sjögren's syndrome: A historical perspective and lessons learned.

Authors:  Harini Bagavant; Aleksandra Michrowska; Umesh S Deshmukh
Journal:  Autoimmun Rev       Date:  2020-10-22       Impact factor: 9.754

Review 2.  Epigenetic regulation of B cells and its role in autoimmune pathogenesis.

Authors:  Fan Xiao; Ke Rui; Xiaofei Shi; Haijing Wu; Xiaoyan Cai; Kathy O Lui; Qianjin Lu; Esteban Ballestar; Jie Tian; Hejian Zou; Liwei Lu
Journal:  Cell Mol Immunol       Date:  2022-10-12       Impact factor: 22.096

3.  Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease.

Authors:  Vinod Burade; Rishit Zalawadia; Alpesh Patel; Abayomi Ogundele
Journal:  Clin Ophthalmol       Date:  2020-09-21

4.  Protocols for Experimental Sjögren's Syndrome.

Authors:  Harini Bagavant; Umesh S Deshmukh
Journal:  Curr Protoc Immunol       Date:  2020-12

5.  MicroRNA expression profile of Lacrimal Glands in rabbit autoimmune dacryoadenitis model.

Authors:  Bo Liu; Lu Zhao; Yankai Wei; Sisi Chen; Lingzhai Bian; Di Guo; Min Gao; Hong Nian
Journal:  Int J Med Sci       Date:  2020-10-16       Impact factor: 3.738

6.  Hyperglycemia and Salivary Gland Dysfunction in the Non-obese Diabetic Mouse: Caveats for Preclinical Studies in Sjögren's Syndrome.

Authors:  Bujana Allushi; Harini Bagavant; Joanna Papinska; Umesh S Deshmukh
Journal:  Sci Rep       Date:  2019-11-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.